首页> 外文期刊>Journal of Medicinal Chemistry >6-Substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid as a core structure for specific inhibitors of human leukocyte elastase.
【24h】

6-Substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid as a core structure for specific inhibitors of human leukocyte elastase.

机译:6-取代的2-氧代-2H-1-苯并吡喃-3-羧酸作为人白细胞弹性蛋白酶特异性抑制剂的核心结构。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Pyridyl esters of 6-substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid were designed as mechanism-based inhibitors of human leukocyte elastase. Compounds of series 4 specifically inhibited this enzyme. Several of the tested compounds (series 2 and 3) acted as powerful time-dependent inhibitors of both human leukocyte elastase and alpha-chymotrypsin; some compounds of these series inhibited thrombin. Trypsin was not inhibited. A transient inactivation was observed for human leukocyte elastase (k(i)/K(I) = 107 000 M(-1). s(-1) for 4c) and thrombin (k(i)/K(I) = 7 200 M(-1).s(-1) for 3b) as demonstrated by spontaneous or hydroxylamine-accelerated reactivation, irrespective of the nature of the substituent at the 6-position. Conversely, alpha-chymotrypsin was irreversibly inhibited by 6-chloromethyl derivatives (k(i)/K(I) = 107 400 M(-1). s(-1) for 3b). The presence of a latent alkylating function at the 6-position (chloromethyl group) was required for leading to this inactivation. In the absence of such an alkylating function (series 4), human leukocyte elastase was specifically inhibited suggesting that this new series of human leukocyte elastase inhibitors may be of potential therapeutic interest in degradative and degenerative processes involving this enzyme.
机译:设计了6-取代的2-氧代-2H-1-苯并吡喃-3-羧酸的吡啶酯作为基于机制的人白细胞弹性蛋白酶抑制剂。系列4的化合物特异性抑制该酶。几种受试化合物(系列2和3)是人白细胞弹性蛋白酶和α-胰凝乳蛋白酶的有力的时间依赖性抑制剂。这些系列的某些化合物可抑制凝血酶。胰蛋白酶不受抑制。观察到人类白细胞弹性蛋白酶(k(i)/ K(I)= 107 000 M(-1)。s(-1)对于4c)和凝血酶(k(i)/ K(I)= 7)暂时失活200 m(-1).s(-1)对于3b),通过自发或羟胺加速的再活化来证明,而与6位取代基的性质无关。相反,α-胰凝乳蛋白酶被6-氯甲基衍生物不可逆地抑制(k(i)/ K(I)= 107 400 M(-1)。s(-1对于3b))。导致这种失活需要在6-位(氯甲基)存在潜在的烷基化功能。在没有这种烷基化功能的情况下(系列4),人类白细胞弹性蛋白酶被特异性抑制,这表明该新系列的人类白细胞弹性酶抑制剂可能在涉及该酶的降解和变性过程中具有潜在的治疗意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号